Vivos Inc. (RDGL)
OTCMKTS · Delayed Price · Currency is USD
0.0473
-0.0023 (-4.68%)
Sep 9, 2026, 3:39 PM EST
Vivos Employees
Vivos had 1 employees as of June 30, 2026.
Employees
1
Change
n/a
Growth
n/a
Revenue / Employee
$99,099
Profits / Employee
-$3,600,842
Market Cap
23.88M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | - | - | 1 | 0 |
| Mar 31, 2026 | 1 | 0 | - | 1 | 0 |
| Dec 31, 2025 | 1 | 0 | - | 1 | 0 |
| Dec 31, 2024 | 1 | 0 | - | 1 | 0 |
| Mar 31, 2024 | 1 | 0 | - | 1 | 0 |
| Dec 31, 2023 | 1 | 0 | - | 1 | 0 |
| Sep 30, 2023 | 1 | 0 | - | 1 | 0 |
| Jun 30, 2023 | 1 | 0 | - | 1 | 0 |
| Mar 31, 2023 | 1 | 0 | - | 1 | 0 |
| Dec 31, 2022 | 1 | 0 | - | 1 | 0 |
| Sep 30, 2022 | 1 | 0 | - | 1 | 0 |
| Jun 30, 2022 | 1 | 0 | - | 1 | 0 |
| Mar 31, 2022 | 1 | 0 | - | 1 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Zomedica | 141 |
| PetVivo Holdings | 22 |
| Tian'an Technology Group | 10 |
| Positron | 10 |
| ALR Technologies SG | 7 |
| Guided Therapeutics | 3 |
Vivos News
- 7 days ago - Vivos Inc. Announces Peer-Reviewed Publication Characterizing PrecisionGel™ Polymer Platform in Elsevier Journal of Drug Delivery Science and Technology - GlobeNewsWire
- 23 days ago - Vivos Inc. Achieves Two Major Operational Milestones: First IsoPet® Shipments from New U.S. Production Facility and Authorization from India's Nuclear Regulatory Authority for International Manufacturing Center - GlobeNewsWire
- 6 weeks ago - Vivos Inc. (OTCQB: RDGL) Reports Second Quarter 2026 Progress and Corporate Update - Correction - GlobeNewsWire
- 6 weeks ago - Vivos Inc. (OTCQB: RDGL) Reports Second Quarter 2026 Progress and Corporate Update - GlobeNewsWire
- 2 months ago - Vivos Inc. (OTCQB: RDGL) Receives U.S. FDA Approval for Investigational Device Exemption (IDE) to Initiate Human Clinical Feasibility Study for RadioGel® Precision Radionuclide Therapy™ - GlobeNewsWire
- 3 months ago - Vivos Inc. Announces Receipt of Washington State Radioactive Materials License for IsoPet® Manufacturing - GlobeNewsWire
- 3 months ago - Vivos Inc. (OTCQB: RDGL) submits Early Feasibility Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) for RadioGel® Precision Radionuclide Therapy™ - GlobeNewsWire
- 6 months ago - Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites - GlobeNewsWire